This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: Nexium plaintiffs' lawsuit an 'assault on capitalism,' juror says

By Richard Vanderford ( December 16, 2014, 22:41 GMT | Comment) -- The closely watched Nexium pay-for-delay case, a recent win for AstraZeneca over drug purchasers, turned in part on jurors who felt that suing a drug innovator was an "assault on capitalism." The comments highlight the uncertainty in taking a complicated antitrust case before a jury.The closely watched Nexium pay-for-delay case, a recent win for AstraZeneca over drug purchasers, turned in part on jurors who felt suing a drug innovator was an "assault on capitalism." The comments highlight the uncertainty in taking a complicated antitrust case before a jury....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections